Detalhe da pesquisa
1.
A RAD51 functional assay as a candidate test for homologous recombination deficiency in ovarian cancer.
Gynecol Oncol
; 171: 106-113, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36868112
2.
Neoadjuvant chemotherapy with or without nintedanib for advanced epithelial ovarian cancer: Lessons from the GINECO double-blind randomized phase II CHIVA trial.
Gynecol Oncol
; 170: 186-194, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36706645
3.
Predicting tumor response and outcome of second-look surgery with 18F-FDG PET/CT: insights from the GINECO CHIVA phase II trial of neoadjuvant chemotherapy plus nintedanib in stage IIIc-IV FIGO ovarian cancer.
Eur J Nucl Med Mol Imaging
; 48(6): 1998-2008, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33221969
4.
Role of supportive care in improving the quality of life and reducing unscheduled hospital care in patients with metastatic breast cancer.
Support Care Cancer
; 29(7): 3735-3742, 2021 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-33205324
5.
Corrigendum to "A RAD51 functional assay as a candidate test for homologous recombination deficiency in ovarian cancer".
Gynecol Oncol
; 175: 194, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37271667
6.
[Needs assessment for the establishment of an Oral Therapy Unit]. / Évaluation des besoins pour la mise en place d'une Unité de Thérapie Orale.
Bull Cancer
; 110(2): 184-192, 2023 Feb.
Artigo
em Francês
| MEDLINE | ID: mdl-36411129
7.
A GINECO randomized phase II trial of two capecitabine and weekly paclitaxel schedules in metastatic breast cancer.
Breast Cancer Res Treat
; 131(1): 127-35, 2012 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-21947680
8.
CA-125 ELIMination Rate Constant K (KELIM) Is a Marker of Chemosensitivity in Patients with Ovarian Cancer: Results from the Phase II CHIVA Trial.
Clin Cancer Res
; 26(17): 4625-4632, 2020 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32209570
9.
[Supportive care for survivors]. / Pour des soins de support de l'après cancer.
Bull Cancer
; 105(9): 763-770, 2018 Sep.
Artigo
em Francês
| MEDLINE | ID: mdl-30097280
10.
["SOS SEIN 84" accelerated breast disease management: Patients satisfaction survey]. / « SOS SEIN 84 ¼ prise en charge rapide en pathologie mammaire : enquête de satisfaction des consultantes.
Bull Cancer
; 103(5): 415-20, 2016 May.
Artigo
em Francês
| MEDLINE | ID: mdl-27040268